NZ242733A - 7-(3-amino acid amino-substituted azetidin-1-yl)-1,4-dihydro-4-oxo-quinoline-(and-1,8-naphthyridine)-3- carboxylic acid derivatives, medicaments, and precursors - Google Patents

7-(3-amino acid amino-substituted azetidin-1-yl)-1,4-dihydro-4-oxo-quinoline-(and-1,8-naphthyridine)-3- carboxylic acid derivatives, medicaments, and precursors

Info

Publication number
NZ242733A
NZ242733A NZ242733A NZ24273392A NZ242733A NZ 242733 A NZ242733 A NZ 242733A NZ 242733 A NZ242733 A NZ 242733A NZ 24273392 A NZ24273392 A NZ 24273392A NZ 242733 A NZ242733 A NZ 242733A
Authority
NZ
New Zealand
Prior art keywords
amino
naphthyridine
medicaments
quinoline
dihydro
Prior art date
Application number
NZ242733A
Inventor
Jordi Corbera-Arjona
Jordi Frigola-Constansa
Juan Pares-Corominas
Original Assignee
Esteve Labor Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Esteve Labor Dr filed Critical Esteve Labor Dr
Publication of NZ242733A publication Critical patent/NZ242733A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/04Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pyridine Compounds (AREA)
NZ242733A 1991-05-16 1992-05-14 7-(3-amino acid amino-substituted azetidin-1-yl)-1,4-dihydro-4-oxo-quinoline-(and-1,8-naphthyridine)-3- carboxylic acid derivatives, medicaments, and precursors NZ242733A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9105937A FR2676445B1 (en) 1991-05-16 1991-05-16 SUBSTITUTED PYRIDONE AMINO ACID AZETIDINYL DERIVATIVES, THEIR PREPARATION AND THEIR APPLICATION AS MEDICAMENTS.

Publications (1)

Publication Number Publication Date
NZ242733A true NZ242733A (en) 1994-06-27

Family

ID=9412841

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ242733A NZ242733A (en) 1991-05-16 1992-05-14 7-(3-amino acid amino-substituted azetidin-1-yl)-1,4-dihydro-4-oxo-quinoline-(and-1,8-naphthyridine)-3- carboxylic acid derivatives, medicaments, and precursors

Country Status (20)

Country Link
EP (1) EP0514268A1 (en)
JP (1) JPH05132479A (en)
KR (1) KR920021528A (en)
CN (1) CN1066656A (en)
AU (1) AU660311B2 (en)
CA (1) CA2068853A1 (en)
CZ (1) CZ147992A3 (en)
ES (1) ES2039192B1 (en)
FI (1) FI922225A (en)
FR (1) FR2676445B1 (en)
HU (1) HUT61304A (en)
IL (1) IL101886A0 (en)
IS (1) IS3862A (en)
MA (1) MA22526A1 (en)
MX (1) MX9202273A (en)
NO (1) NO921908L (en)
NZ (1) NZ242733A (en)
OA (1) OA09794A (en)
PL (1) PL294561A1 (en)
ZA (1) ZA923538B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE289999T1 (en) * 1996-07-12 2005-03-15 Daiichi Seiyaku Co CIS-SUBSTITUTED AMINOCYCLOPROPANE DERIVATIVES
KR100613690B1 (en) * 2004-07-30 2006-08-21 한국화학연구원 4-quinolinone derivative and fungicidal composition for agriculture and horticulture comprising same
KR100613688B1 (en) * 2004-08-30 2006-08-21 한국화학연구원 2-amino-4-quinolinone derivative and fungicidal composition for agriculture and horticulture comprising same
CN101291683B (en) 2004-11-24 2011-08-17 纽普罗研究有限公司 Methods and compositions for treating conditions
CA2647835A1 (en) 2006-03-28 2007-10-04 Neopro Labs, Llc Methods and compositions for treating conditions
CA2683288A1 (en) 2007-05-17 2008-11-27 Neopro Labs, Llc Crystalline and amorphous forms of peptide
CN101898990B (en) * 2009-06-01 2012-12-19 中国科学院化学研究所 Method for catalyzing and synthesizing chirality azetidine amide and carboxylic acid compound by microorganism system

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5746986A (en) * 1980-09-02 1982-03-17 Dai Ichi Seiyaku Co Ltd Pyrido(1,2,3-de)(1,4)benzoxazine derivative
IE55898B1 (en) * 1982-09-09 1991-02-14 Warner Lambert Co Antibacterial agents
DE3306771A1 (en) * 1983-02-25 1984-08-30 Bayer Ag, 5090 Leverkusen CHINOLONIC CARBONIC ACIDS, METHOD FOR THE PRODUCTION THEREOF AND THE ANTIBACTERIAL AGENTS CONTAINING THEM
JPH0665676B2 (en) * 1984-04-26 1994-08-24 アボツト ラボラトリーズ Quinoline-benoxazine antibacterial compounds
US4617308A (en) * 1985-01-25 1986-10-14 Warner-Lambert Company 7-substituted amino-1-aryl-6,8-difluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acids and derivatives thereof as antibacterial agents
US4851418A (en) * 1987-08-21 1989-07-25 Warner-Lambert Company Naphthyridine antibacterial agents containing an α-amino acid in the side chain of the 7-substituent
FR2634483B2 (en) * 1987-12-29 1994-03-04 Esteve Labor Dr DERIVATIVES OF ACIDS 7- (1-AZETIDINYL) -1,4-DIHYDRO-4-OXOQUINOLEINE-3-CARBOXYLIQUES, THEIR PREPARATION AND THEIR APPLICATION AS MEDICAMENTS
IE76284B1 (en) * 1988-09-22 1997-10-08 Abbott Lab Amino acid quinoline and naphthyridine derivatives
FI901201A0 (en) * 1989-03-13 1990-03-09 Bristol Myers Squibb Co ANTIBAKTERIELLA 5-SUBSTITUERADE 1,4-DIHYDRO-4-OXONAFTYRIDIN-3-CARBOXYLATDERIVAT OCH DERAS FRAMSTAELLNING.
NO177302C (en) * 1989-03-16 1995-08-23 Esteve Labor Dr Analogous Process for Preparing Therapeutically Active Substituted Azetidinyl Quinolone (Naphthyridone) Carboxylic Acid Derivatives
FR2645862B1 (en) * 1989-04-18 1991-07-12 Esteve Labor Dr SUBSTITUTED ISOTHIAZOLO-PYRYDONE AZETIDINYL DERIVATIVES, THEIR PREPARATION AND THEIR APPLICATION AS MEDICAMENTS
FR2649100B1 (en) * 1989-06-29 1994-03-04 Laboratorios Dr Esteve Sa NOVEL AZETIDINES, THEIR PREPARATION AND THEIR APPLICATION AS INTERMEDIATES FOR THE PREPARATION OF COMPOUNDS WITH ANTIMICROBIAL ACTIVITY

Also Published As

Publication number Publication date
NO921908D0 (en) 1992-05-14
IS3862A (en) 1992-11-17
MX9202273A (en) 1993-05-01
HU9201621D0 (en) 1992-08-28
MA22526A1 (en) 1992-12-31
FR2676445B1 (en) 1995-02-03
PL294561A1 (en) 1993-05-04
IL101886A0 (en) 1992-12-30
KR920021528A (en) 1992-12-18
HUT61304A (en) 1992-12-28
ES2039192B1 (en) 1994-04-01
CN1066656A (en) 1992-12-02
AU660311B2 (en) 1995-06-22
CZ147992A3 (en) 1993-09-15
FI922225A (en) 1992-11-17
EP0514268A1 (en) 1992-11-19
CA2068853A1 (en) 1992-11-17
JPH05132479A (en) 1993-05-28
FR2676445A1 (en) 1992-11-20
OA09794A (en) 1994-04-15
AU1624992A (en) 1992-11-19
ES2039192A1 (en) 1993-09-01
NO921908L (en) 1992-11-17
ZA923538B (en) 1993-01-27
FI922225A0 (en) 1992-05-15

Similar Documents

Publication Publication Date Title
HUP9901478A3 (en) Carboline derivatives, their use, production thereof and medicaments containing the same
IL112193A (en) 6-(2-arylpyrazolo¬1,5-A¾pyridine-3-yl)-2-substituted pyridazin-3(2H)-one derivatives processes for the preparation thereof and pharmaceutical compositions containing them
IL87809A0 (en) Imidazopyridine derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
IL87731A (en) Cephem derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
HU208256B (en) Process for producing pharmaceutical compositions suitable for the selective reduction of lipoid level of blood
PL299929A1 (en) Quinoxaline derivatives, method of obtaining sames and their use in drugs
AU644540B2 (en) Imidazopyridine derivatives and process for preparation thereof
NZ242733A (en) 7-(3-amino acid amino-substituted azetidin-1-yl)-1,4-dihydro-4-oxo-quinoline-(and-1,8-naphthyridine)-3- carboxylic acid derivatives, medicaments, and precursors
HU9400478D0 (en) Process for the preparation of beta-phenylisoserine derivatives and use thereof
AU2141695A (en) Imidazo{1,2-a}pyrazine-4-one derivatives, preparation thereof and drugs containing same
NZ229346A (en) Oxadiazolyl-substituted imidazo(1,5-a)quinoxaline derivatives and pharmaceutical compositions
HUT70955A (en) 3,4-dihydro-1,1-dioxo-2h-1,2,4-benzothiadiazine-3-carboxylic acid derivatives, preparation thereof and drugs containing same
NZ224032A (en) Imidazo(1,2-a)pyridine derivatives and pharmaceutical compositions
EP0577725A4 (en) Targeted drug delivery via mixed phosphate derivatives
EP0556671A3 (en) Triazolopyridine derivatives, process for their preparation and their use as microbicides
AU2457688A (en) New fluoromethoxyphenyl dihydropyridines, processes for the preparation and their use in medicaments
NZ238428A (en) Cephalosporin derivatives and medicaments
IL84331A0 (en) Pyridoxyl hydrazone derivatives and pharmaceutical compositions containing the same
HUP9802736A3 (en) Use of 1,4-dihydropyridine derivatives for the preparation of medicament for the prevention and therapy of atherosclerotic degradation in the arterial walls
HUT57776A (en) Process for producing pyrido(3,4-b)(1,4)benzoxazepine derivatives and pharmaceutical compositions comprising same
ZA872443B (en) Bis-tert.butylamino-substituted 1,3,5-triazine derivatives,processes for their preparation,medicaments containing these compounds and their use
EP0549263A3 (en) A process for the preparation of n-alkyl-3,4-dialkyloxyanilines and derivatives thereof
NZ226494A (en) 2,3-dioxabicyclo(3.3.1)nonan-7-one derivatives, medicaments and precursors
GB2270313B (en) 1,3,4-Benzotriazepin-5 (4H)-one derivatives and process for the preparation thereof
AU3084992A (en) 1,4-dihydropyridines for use in the treatment of dermatosis